$TGTX Stock Set For Breakout Amidst Symmetrical Triangle Pattern

TG Therapeutics, Inc. (NASDAQ: TGTX) a biopharmaceutical company, that focuses on the acquisition, development, and commercialization of novel treatments for B-cell mediated diseases in the United States and internationally is set for a breakout amidst a bullish symmetrical triangle pattern.

Analyst Forecast
According to 6 analysts, the average rating for TGTX stock is "Strong Buy." The 12-month stock price forecast is $40.67, which is an increase of 35.16% from the latest price.

Important Dates
The next confirmed earnings date is Monday, March 3, 2025, before market open.

On How the bullish symmetrical plays out is largely incumbent on the earnings report slated for today Monday March 3, 2025 before the bell.